MRI Virtual Biopsy of T2 Hyperintense Breast Lesions
Overview
Affiliations
A wide variety of benign and malignant breast processes may generate hyperintense signal at T2-weighted magnetic resonance imaging (MRI). MRI has been traditionally used in the pre-treatment planning of breast cancer, in assessing treatment response and detecting recurrence. In this comprehensive review, we describe and illustrate the MRI features of a few common and uncommon T2 hyperintense breast lesions, with an emphasis on MRI features that help to characterize lesions based on morphological features, specific appearances on T1-and T2-weighted imaging, and enhancement characteristics on the dynamic post-contrast phase that are either diagnostic or aid in narrowing the differential diagnosis.
Wei Z, Chen X, Yang Y, Yang L, Ma X Transl Cancer Res. 2024; 13(8):4042-4051.
PMID: 39262467 PMC: 11384317. DOI: 10.21037/tcr-24-498.
Mouhammed K, Gdoura R Indian J Microbiol. 2024; 64(2):457-466.
PMID: 39011020 PMC: 11246310. DOI: 10.1007/s12088-023-01123-3.
Dhabalia R, Kashikar S, Parihar P, Mishra G Cureus. 2024; 16(2):e54808.
PMID: 38529430 PMC: 10961652. DOI: 10.7759/cureus.54808.
Bissell M, Keshavarsi S, Fleming R, Au F, Kulkarni S, Ghai S Breast Cancer Res Treat. 2024; 205(1):159-168.
PMID: 38305940 DOI: 10.1007/s10549-023-07239-w.
Otikovs M, Nissan N, Furman-Haran E, Anaby D, Agassi R, Sklair-Levy M Diagnostics (Basel). 2023; 13(23).
PMID: 38066757 PMC: 10705897. DOI: 10.3390/diagnostics13233516.